1. Pink Sheet
  2. >>Geography
  3. >>Europe

European Countries Step Up Efforts To Tackle Monkeypox

 
• By Ian Schofield

The UK says a “proportionate” approach to tackling monkeypox is needed, and that Imvanex is now available for vaccination. France has issued a decree authorizing the use of Imvanex and the importation of its US equivalent, Jynneos, and Germany has ordered thousands of doses of the vaccine. SIGA’s antiviral tecovirimat can also be used for monkeypox in the EU.  

Vaccination for booster shot for Smallpox and Monkeypox (MPXV).
Vaccines are being made available for the response to monkeypox cases • Source: Shutterstock

With UK cases of monkeypox now having soared to 190, the country’s four public health agencies have issued a joint statement outlining a set of proposals for suppressing transmission of the disease in the community, including the use of Bavarian Nordic’s smallpox vaccine, Imvanex.

“Pre- and-post exposure prophylaxis using Imvanex is available for deployment,” according to the statement, which was agreed by the UK Health Security Agency (UKHSA), Public Health

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

EMA Explores Using AI Language Models To Refine Oncology Guidance

 
• By Vibha Sharma

The European Medicines Agency has for the first time explicitly stated it is considering the use of large language models as a tool to improve the readability of a scientific guideline.

Industry On Making England’s HTA Innovation Lab A Success

 
• By Eliza Slawther

England’s health technology assessment institute, NICE, must ensure that there is clarity for manufacturers on how its methods and processes might change following testing in its sandbox environment, the Association of the British Pharmaceutical Industry said.

US FDA Rare Disease Case Studies Provide Development Models For Sponsors

 
• By Laura Helbling

Sanofi’s Xenpozyme and Sentynyl’s Nulibry are the first two case studies the FDA is using to continue educating rare disease sponsors on best practices.